Contessa, the innovation and high-acuity arm of Amedisys Inc. (NASDAQ: AMED) has made large investments in expanding access to palliative care, particularly through joint ventures with health systems. Amedisys acquired Contessa in 2021 for $250 million. The subsidiary’s specialty is high-acuity care in the home, including hospital-at-home and skilled nursing facility-at-home programs, but in recent […]
Contessa
Want to read more palliative care-focused content like this? Subscribe to Palliative Care News today! With the palliative care space in a state of flux, some experts in the field see cause for optimism as well as real questions about what these services will look like, as well as the structures that support them. “Palliative care” […]
Want to read more palliative care-focused content like this? Subscribe to Palliative Care News today! Amedisys (NASDAQ: AMED) is pushing forward on palliative care growth in 2024 through its innovation arm, Contessa. The company acquired Contessa in 2021 for $250 million. Contessa’s specialties are high-acuity care in the home, including hospital-at-home and skilled nursing facility-at-home programs. […]
An increasingly diverse base of health care providers have taken an interest in the palliative care space, a trend that could be indicative of how strategic growth is taking shape in the field. As they build out their palliative care programs, many of these organizations are pursuing partnerships to foster coordination and growth. A range […]
As Contessa Health pioneers a growing value-based palliative care-at-home program, they’ve encountered some learning curves when it comes to operating within a new payment system. Contessa is a subsidiary of Amedisys (NASDAQ: AMED), which the home health and hospice provider acquired in 2021 for $250 million. Contessa’s specialty is high-acuity care in the home, including […]
The palliative care space is at an inflection point at which unprecedented awareness and demand are fueling growth that could be hampered by limited reimbursement and staffing shortages. Palliative Care News spoke with a group of industry leaders about the most impactful forces that will shape the space in the coming year. Some of the […]
Establishing consistent relationships with referral sources will not only fill palliative care programs’ business pipelines, but it will also allow providers to develop better delivery models to meet the needs of their partners and patients. As value-based models expand and hold health systems accountable for the entire care continuum, palliative care partnerships and joint ventures […]
Negotiations around Amedisys Inc.’s (NASDAQ: AMED) Contessa subsidiary were a significant contributor to the pendulum swing that led to the company’s acquisition by UnitedHealth Group’s (NYSE: UNH) Optum rather than Option Care Health (NASDAQ: OPCH). Optum in June penned its agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 […]
High-acuity care in the home has become an admissions growth engine for Amedisys (NASDAQ: AMED), which the company delivers through its subsidiary Contessa. Combined, hospital-at-home and skilled nursing facility-at-home admissions grew by 55% year-over-year during the second quarter of the year. This is compared to a 4% increase in home health same-store admissions and a […]
As the demand for palliative care continues to grow, so too has the way businesses have bolstered their programs to better serve patients. Providers are consistently looking for new methods to deliver responsive, value-based services that can generate savings and reduce high-acuity utilization. Hospice News spoke with three palliative care providers that have risen to […]